Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher L. Moertel
CD200 Checkpoint Reversal:A Novel Approach to Immunotherapy
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Local Angiotensin II Contributes to Tumor Resistance to Checkpoint Immunotherapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Joint Approach to Immunotherapy Biomarkers
Cancer Discovery
Oncology
Defining T Cell States Associated With Response to Checkpoint Immunotherapy in Melanoma
Cell
Biochemistry
Genetics
Molecular Biology
Prediction of Clinical Response to Checkpoint Blockade Immunotherapy Is Improved With Ensembling
Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
CTLA4Ig Primed Donor Lymphocyte Infusion: A Novel Approach to Immunotherapy Following Haploidentical Transplantation for Advanced Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
WEE1 Kinase Inhibition Reverses G2/M Cell Cycle Checkpoint Activation to Sensitize Cancer Cells to Immunotherapy
OncoImmunology
Oncology
Allergy
Immunology
Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy
Mayo Clinic Proceedings
Medicine
Novel Approaches of Immunotherapy
Current Treatment Options in Allergy